Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biswas, D. K.
Right arrow Articles by Pardee, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biswas, D. K.
Right arrow Articles by Pardee, A. B.
[Cancer Research 63, 290-295, January 15, 2003]
© 2003 American Association for Cancer Research


Advances in Brief

Apoptosis Caused by Chemotherapeutic Inhibition of Nuclear Factor-{kappa}B Activation1

Debajit K. Biswas2, Katherine J. Martin, Cliona McAlister, Antonio P. Cruz, Edgard Graner, Sun-chun Dai and Arthur B. Pardee

Dana-Farber Cancer Institute, Department of Cancer Biology, Boston, Massachusetts 02115

Both the protein kinase C ({alpha}/ß) inhibitor Go6976 and expression of dominant-negative nuclear factor (NF)-{kappa}B inhibitor kinase mutants: (a) blocked the growth and caused regression of a mammary tumor insyngeneic mice; (b) inhibited epidermal growth factor (EGF)-induced activation, nuclear translocation, and DNA-binding activity of NF-{kappa}B; and (c) caused apoptosis of EGF-stimulated cultured mammary tumor cells. cDNA microarray analysis revealed that these treatments reversed the expression changes of a subset of genes altered by EGF treatment. These included: up-regulation of proapoptotic genes of the tumor necrosis factor (TNF) pathway, death-associated protein (DAP) kinase, p53, and p21/Waf1; and down-regulation of inhibitors of apoptosis: inhibitor of apoptosis(IAP)-1 and X-IAP, TNF receptor-associated factor (TRAF)-2, and factors OX40 and 4-1BB. These results and our previous studies suggest the practicality of a target-directed chemotherapy for EGF-responsive breast cancers, by blocking NF-{kappa}B activation and thereby reinstating apoptosis.




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
N. Deniel, R. Marion-Letellier, R. Charlionet, F. Tron, J. Leprince, H. Vaudry, P. Ducrotte, P. Dechelotte, and S. Thebault
Glutamine Regulates the Human Epithelial Intestinal HCT-8 Cell Proteome under Apoptotic Conditions
Mol. Cell. Proteomics, October 1, 2007; 6(10): 1671 - 1679.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Singh, Q. Shi, S. T. Bailey, M. J. Palczewski, A. B. Pardee, J. D. Iglehart, and D. K. Biswas
Nuclear factor-{kappa}B activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer
Mol. Cancer Ther., July 1, 2007; 6(7): 1973 - 1982.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Ciucci, P. Gianferretti, R. Piva, T. Guyot, T. J. Snape, S. M. Roberts, and M. G. Santoro
Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the I{kappa}B Kinase/Nuclear Factor-{kappa}B Pathway
Mol. Pharmacol., November 1, 2006; 70(5): 1812 - 1821.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
V. Aaltonen, J. Koivunen, M. Laato, and J. Peltonen
Heterogeneity of Cellular Proliferation within Transitional Cell Carcinoma: Correlation of Protein Kinase C Alpha/betaI Expression and Activity
J. Histochem. Cytochem., July 1, 2006; 54(7): 795 - 806.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. A. Buchholz, A. K. Garg, N. Chakravarti, B. B. Aggarwal, F. J. Esteva, H. M. Kuerer, S. E. Singletary, G. N. Hortobagyi, L. Pusztai, M. Cristofanilli, et al.
The Nuclear Transcription Factor {kappa}B/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
Clin. Cancer Res., December 1, 2005; 11(23): 8398 - 8402.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos, and J. E. Price
Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-{kappa}B Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice
Clin. Cancer Res., October 15, 2005; 11(20): 7490 - 7498.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. D. Emberley, Y. Niu, L. Curtis, S. Troup, S. K. Mandal, J. N. Myers, S. B. Gibson, L. C. Murphy, and P. H. Watson
The S100A7-c-Jun Activation Domain Binding Protein 1 Pathway Enhances Prosurvival Pathways in Breast Cancer
Cancer Res., July 1, 2005; 65(13): 5696 - 5702.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Baetz, J. Shaw, and L. A. Kirshenbaum
Nuclear Factor-{kappa}B Decoys Suppress Endotoxin-Induced Lung Injury
Mol. Pharmacol., April 1, 2005; 67(4): 977 - 979.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. V. Starenki, H. Namba, V. A. Saenko, A. Ohtsuru, S. Maeda, K. Umezawa, and S. Yamashita
Induction of Thyroid Cancer Cell Apoptosis by a Novel Nuclear Factor {kappa}B Inhibitor, Dehydroxymethylepoxyquinomicin
Clin. Cancer Res., October 15, 2004; 10(20): 6821 - 6829.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Koivunen, V. Aaltonen, S. Koskela, P. Lehenkari, M. Laato, and J. Peltonen
Protein Kinase C {alpha}/{beta} Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells
Cancer Res., August 15, 2004; 64(16): 5693 - 5701.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. K. Biswas, Q. Shi, S. Baily, I. Strickland, S. Ghosh, A. B. Pardee, and J. D. Iglehart
NF-{kappa}B activation in human breast cancer specimens and its role in cell proliferation and apoptosis
PNAS, July 6, 2004; 101(27): 10137 - 10142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. C. Maiuri, G. Tajana, T. Iuvone, D. De Stefano, G. Mele, M. T. Ribecco, M. P. Cinelli, M. F. Romano, M. C. Turco, and R. Carnuccio
Nuclear Factor-{kappa}B Regulates Inflammatory Cell Apoptosis and Phagocytosis in Rat Carrageenin-Sponge Implant Model
Am. J. Pathol., July 1, 2004; 165(1): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. H. Rendi, N. Suh, W. W. Lamph, S. Krajewski, J. C. Reed, R. A. Heyman, A. Berchuck, K. Liby, R. Risingsong, D. B. Royce, et al.
The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor {beta}-Dependent Apoptosis in Breast Cancer
Cancer Res., May 15, 2004; 64(10): 3566 - 3571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Waxman and P. S. Schwartz
Harnessing Apoptosis for Improved Anticancer Gene Therapy
Cancer Res., December 15, 2003; 63(24): 8563 - 8572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Anto, M. Venkatraman, and D. Karunagaran
Inhibition of NF-{kappa}B Sensitizes A431 Cells to Epidermal Growth Factor-induced Apoptosis, whereas Its Activation by Ectopic Expression of RelA Confers Resistance
J. Biol. Chem., July 3, 2003; 278(28): 25490 - 25498.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.